Pharma Firms Push for Sharing Of Cancer Trial Data

摘要

Of the hundreds of compounds that undergo clinical trials for use in cancer therapy, less than 5% make it to the pharmacist's shelf, a success rate lower than that for experimental drugs in most other fields of medicine. Now, a consortium of pharmaceutical companies hopes to improve that frustrat-ingly inefficient enterprise by getting cancer researchers to share data from clinical trials. Called DataSphere, the effort aims to create a repository of data sets from cancer trials conducted by drug companies, academic labs, and other organizations.